The China Alzheimer Report 2022
Authors:
Top Cited Papers
Open Access
- 1 January 2022
- journal article
- review article
- Published by Wiley in General Psychiatry
- Vol. 35 (1) , e100751
Abstract
China’s population has rapidly aged over the recent decades of social and economic development as neurodegenerative disorders have proliferated, especially Alzheimer’s disease (AD) and related dementias (ADRD). AD’s incidence rate, morbidity, and mortality have steadily increased to make it presently the fifth leading cause of death among urban and rural residents in China and magnify the resulting financial burdens on individuals, families and society. The ‘Healthy China Action’ plan of 2019–2030 promotes the transition from disease treatment to health maintenance for this expanding population with ADRD. This report describes related epidemiological trends, evaluates the economic burden of the disease, outlines current clinical diagnosis and treatment status and delineates existing available public health resources. More specifically, it examines the public health impact of ADRD, including prevalence, mortality, costs, usage of care, and the overall effect on caregivers and society. In addition, this special report presents technical guidance and supports for the prevention and treatment of AD, provides expertise to guide relevant governmental healthcare policy development and suggests an information platform for international exchange and cooperation.Keywords
Funding Information
- Ministry of Science and Technology of the People's Republic of China (2021ZD0201804)
- Ministry of Science and Technology of the People's Republic of China (2021ZD0201804)
This publication has 64 references indexed in Scilit:
- TRPC6 specifically interacts with APP to inhibit its cleavage by γ-secretase and reduce Aβ productionNature Communications, 2015
- Global, regional, and national disability-adjusted life years (DALYs) for 306 diseases and injuries and healthy life expectancy (HALE) for 188 countries, 1990–2013: quantifying the epidemiological transitionThe Lancet, 2015
- Amyloid-β 42/40 Cerebrospinal Fluid Concentration Ratio in the Diagnostics of Alzheimer's Disease: Validation of Two Novel AssaysJournal of Alzheimer’s Disease, 2014
- Accuracy of Urinary AD7c-NTP for Diagnosing Alzheimer's Disease: A Systematic Review and Meta-AnalysisJournal of Alzheimer’s Disease, 2014
- Validation of the Chinese Version of Addenbrooke's Cognitive Examination-Revised for Screening Mild Alzheimer's Disease and Mild Cognitive ImpairmentDementia and Geriatric Cognitive Disorders, 2013
- Cerebral amyloid PET imaging in Alzheimer’s diseaseActa Neuropathologica, 2013
- Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010The Lancet, 2012
- Competitive ELISA studies of neural thread protein in urine in Alzheimer's diseaseJournal of Clinical Laboratory Analysis, 2007
- Staging of alzheimer's disease-related neurofibrillary changesNeurobiology of Aging, 1995
- A Chinese version of the mini-mental state examination; Impact of illiteracy in a Shanghai dementia surveyJournal of Clinical Epidemiology, 1988